Evidence that treatment prevents transition to psychosis in ultra-high-risk patients remains questionable

Schizophrenia Research

Volumn 153, Issue 1-3, 2014, Pages 240-

  Amos, Andrew James ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Gold Coast Hospital and Health Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

COGNITIVE THERAPY; DRUG EFFICACY; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; INTEGRATED PSYCHOLOGICAL INTERVENTION; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; LETTER; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; PSYCHOSIS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; FEMALE; LONGITUDINAL STUDY; MALE; PSYCHOTIC DISORDERS;

FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84895796502     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.01.003     Document Type: Letter

References (6)

1. Amminger G.P., Schäfer M.R., Papageorgiou K., Klier C.M., Cotton, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch. Gen. Psychiatry 2010, 67(2):146-154.
2. Button K.S., Ioannidis J.P., Mokrysz C., Nosek B.A., Flint J., Robinson E.S.J., Munafò M.R. Power failure: why small sample size undermines the reliability of neuroscience. Nat. Rev. Neurosci. 2013, 14(5):365-376.
3. McGorry P.D. Beyond DSM: early stages of disorder pose predictable and modifiable risk for persistent disorder. Aust. N. Z. J. Psychiatry 2013, 47(9):880-881.
4. Morrison A.P., French P., Walford L., Lewis S.W., Kilcommons A., et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br. J. Psychiatry 2004, 185:291-297.
5. Van der Gaag M., Nieman D.H., Rietdijk J., Dragt S., Ising H.K., et al. Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial. Schizophr. Bull. 2012, 38(6):1180-1188.
6. Van der Gaag M., Smit F., Bechdolf A., French P., Linszen D.H., et al. Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12month and longer-term follow-ups. Schizophr. Res. 2013, 149(1-3):56-62.